Jieming Qu
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Genetics top 2%
- Mesenchymal stem cell research
Papers in
-
- Neonatal Respiratory Health Research 11
- Respiratory Support and Mechanisms 6
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 7
- Antifungal resistance and susceptibility 6
- Co-authors
- Yinggang Zhu (16 shared papers)Xinxin Zhang (4 shared papers)Min Zhou (4 shared papers)Antoine Monsel (7 shared papers)Jing Zhang (15 shared papers)Michael A. Matthay (1 shared paper)Xiaomei Feng (1 shared paper)Xiaohui Fang (1 shared paper)
- Journals
- Inflammation Research (5 papers)Acta Pharmacologica Sinica (4 papers)Clinical and Translational Medicine (3 papers)Nature Communications (3 papers)Frontiers in Microbiology (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jieming Qu
116 papers receiving 4.2k citations
Jieming Qu's Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Medicine 280
- Genetics 517
- Infectious Diseases 701
- Cancer Research 407
- Pulmonary and Respiratory Medicine 833
Countries citing papers authored by Jieming Qu
This map shows the geographic impact of Jieming Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieming Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieming Qu more than expected).
Fields of papers citing papers by Jieming Qu
This network shows the impact of papers produced by Jieming Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieming Qu. The network helps show where Jieming Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieming Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice Hit paper breakdown → | 2013 | 561 |
| 2 | 2020 | 323 | |
| 3 | 2017 | 202 | |
| 4 | 2008 | 201 | |
| 5 | 2017 | 190 | |
| 6 | 2006 | 173 | |
| 7 | Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles Hit paper breakdown → | 2021 | 168 |
| 8 | 2017 | 148 | |
| 9 | Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study Hit paper breakdown → | 2022 | 143 |
| 10 | 2013 | 130 | |
| 11 | 2021 | 127 | |
| 12 | 2021 | 109 | |
| 13 | 2019 | 99 | |
| 14 | 2020 | 93 | |
| 15 | 2020 | 88 | |
| 16 | 2016 | 62 | |
| 17 | 2015 | 54 | |
| 18 | 2012 | 49 | |
| 19 | 2023 | 43 | |
| 20 | 2010 | 41 |
About Jieming Qu
Jieming Qu is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Molecular Biology, Immunology and Epidemiology, having authored 119 papers that have together received 4.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Neonatal Respiratory Health Research (11 papers), Antibiotic Resistance in Bacteria (9 papers), Immune Response and Inflammation (8 papers), Mesenchymal stem cell research (7 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Respiratory Support and Mechanisms (6 papers) and Antifungal resistance and susceptibility (6 papers). The work is most often cited by research in Molecular Medicine (280 citations), Genetics (517 citations), Infectious Diseases (701 citations), Cancer Research (407 citations) and Pulmonary and Respiratory Medicine (833 citations). Jieming Qu has collaborated with scholars based in China, United States and France. Frequent co-authors include Yinggang Zhu, Xinxin Zhang, Min Zhou, Antoine Monsel, Jing Zhang, Michael A. Matthay, Xiaomei Feng, Xiaohui Fang, Jason Abbott and Hao Qi. Their work appears in journals such as Inflammation Research, Acta Pharmacologica Sinica, Clinical and Translational Medicine, Nature Communications and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.